Welcome to Phacilitate’s inaugural SIG – a unique and exclusive think tank drawing together the cell & gene therapy sector’s manufacturing decision makers with the ‘do-ers’: namely the bioprocess developers and engineers tasked with sourcing, selecting and implementing automated solutions.
What exactly is this event about?
- A select group delivering a roadmap to cost-effective, robust and interconnected ‘vein to vein’ manufacturing and supply chain models
- A highly immersive blend of intense brainstorming sessions and innovative, activity-based networking in an exclusive location geared to optimising interaction
- The source of a variety of invaluable, tangible ‘take-homes’ variously defining for participants and their organisations:
- the technical state-of-the-art in automation today
- the affordability and ROI from automation at each stage of cell & gene therapy R&D/commercialisation
- The only event to specifically examine automation relating to product characterisation, quality testing, raw/starting materials and logistics tools and processes, in addition to bioprocessing systems
- A ‘landing point’ in cell & gene therapy for leading bioengineers from the fringes of the sector
- An opportunity for each and every attendee to bring a specific issue or challenge to the table for discussion by the group
- The perfect setting to develop genuinely valuable and lasting new contacts
What you will gain from from participation?
- Establish your tools and services as a key component in the vein-to-vein models of the future (be part of the ONLY directory for automated cell and gene therapy solutions)
- Demonstrate the ROI for automation in cell and gene therapy
- Show technicians how to integrate your solution into their workflow
- 2 birds, 1 stone: demonstrate to the do-ers, strategize with their Win the race: Meet biotechs BEFORE they execute their automation strategy
- Have your voice heard: Be a part of a peer-reviewed automation manifesto
- Directly influence the technological decisions and strategic agenda through invitationonly focus groups
- Create a feedback loop: Run a user group meeting and improve your products
The programme for Phacilitate SIG: Automation is now being developed, driven in large part by input from our stellar Steering Committee.
Members confirmed to date include:
- Dr Stefano Baila, Process Development Manager, Celyad
- Dr Dolores Baksch, Innovation Leader, Cell Therapy Technologies, GE Healthcare
- David Brindley, DPhil, MEng, FRSA, Senior Research Fellow in Healthcare Translation, Department of Paediatrics, University of Oxford
- Kim Bure, Director, Regenerative Medicine, Sartorius Stedim Biotech
- Professor John Campbell, Associate Director, Research, Development & Innovation, Scottish National Blood Transfusion Service (SNBTS)